(secondQuint)Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple Myeloma.

 Treatment: Patients will take three 50 mg tablets of perifosine qhs daily with food.

 All patients should continue therapy unless disease progression is documented on two occasions at least 1 week apart.

 Progressing patients will have dexamethasone 20 mg twice per week added to the perifosine.

 Patients who experience toxicity may continue on treatment with doses delayed or reduced.

 Evaluations: Serum and/or urine-electrophoresis will be evaluated for progression or response at 3 week intervals.

 This study will enroll a total of up to 64 patients.

.

 Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple Myeloma@highlight

This is a phase 2 study of perifosine in patients with multiple myeloma.

 Patients will receive perifosine 150 mg at bedtime (qhs) daily.

 Patients will be assessed by serum and/or urine-electrophoresis at least every 3 weeks.

